[Synthesis of the guidelines for the treatment of non-neurological urinary incontinence in women].
The last two decades have brought about new medical and surgical treatments revolutionizing care for non-neurological urinary incontinence in women. Many studies, often randomized prospective studies with sufficient follow-up, have validated the therapeutic choices and shown them not to be part of a fad or marketing pressures. The French Association of Urology (L'Association Française d'Urologie), through its Committee on Women's Urology and Pelviperineology (Comité d'Urologie et de Pelvipérinéologie de la Femme), proposes its recommendations. These were established by an expert group of specialists (urologists, gynecologists, and physical therapists), based on a review of the literature but taking into account the daily practices in academic and private practice settings. Between evidence-based medicine and reality in the field, these recommendations attempt to propose realistic and applicable strategies.
Hermieu
J-F
JF
jean-francois.hermieu@bch.aphp.fr
Conquy
S
S
Leriche
B
B
Debodinance
P
P
Delorme
E
E
Boccon Gibod
L
L
Cortesse
A
A
Vidart
A
A
Cour
F
F
Richard
F
F
Cardot
V
V
Berlizot
P
P
Lenormand
L
L
Ragni
E
E
Peyrat
L
L
Yiou
R
R
Ballanger
P
P
D001905:Botulinum Toxins / Q000627:therapeutic use; D003663:Decision Trees; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D053825:Suburethral Slings; D014549:Urinary Incontinence / Q000628:therapy*
D009465:Neuromuscular Agents; D001905:Botulinum Toxins